New data demonstrating the strength of Novartis' hematology portfolio to be presented - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
New data demonstrating the strength of Novartis' hematology portfolio to be presented

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

12-02-2009, 05:14 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	New data demonstrating the strength of Novartis' hematology portfolio to be presented Novartis announced today that new data, including a late-breaking presentation on Tasigna® (nilotinib) 200 mg capsules in a form of chronic myeloid leukemia, demonstrate the strength of the company's hematology portfolio in advancing the care of patients. More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 11:22 AM.

free webpage hit counter